Bottom line
How much do JDOC and RYHIX overlap?
64% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 55.5% of JDOC's assets and 25.3% of RYHIX's. They share a meaningful core but differ in the rest of the portfolio.
RYHIX holds far more positions (135 vs 61), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings JDOC and RYHIX have in common
| Holding | % of JDOC | % of RYHIX | Overlap |
|---|---|---|---|
| AbbVie, Inc. | 7.85% | 2.52% | 2.52% |
| Eli Lilly & Co. | 7.76% | 3.63% | 3.63% |
| UnitedHealth Group, Inc. | 5.85% | 2.22% | 2.22% |
| Merck & Co., Inc. | 4.82% | 2.04% | 2.04% |
| Johnson & Johnson | 4.82% | 2.88% | 2.88% |
| Thermo Fisher Scientific, Inc. | 3.73% | 1.61% | 1.61% |
| Bristol-Myers Squibb Co. | 3.57% | 1.22% | 1.22% |
| Abbott Laboratories | 3.11% | 1.42% | 1.42% |
| CVS Health Corp. | 2.83% | 1.31% | 1.31% |
| Stryker Corp. | 2.23% | 1.21% | 1.21% |
| Danaher Corp. | 2.16% | 1.30% | 1.30% |
| Intuitive Surgical, Inc. | 1.93% | 1.31% | 1.31% |
| Edwards Lifesciences Corp. | 1.73% | 0.84% | 0.84% |
| Regeneron Pharmaceuticals, Inc. | 1.60% | 0.90% | 0.90% |
| Cardinal Health, Inc. | 1.51% | 0.86% | 0.86% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in JDOC
- AstraZeneca plc — 3.76%
- Roche Holding AG — 2.82%
- Novo Nordisk A/S — 2.61%
- GSK plc — 2.47%
- Cencora, Inc. — 2.07%
- Argenx SE — 2.06%
- IQVIA Holdings, Inc. — 1.71%
- Teva Pharmaceutical Industries Ltd. — 1.60%
- Novartis AG — 1.60%
- Biogen, Inc. — 1.56%
Only in RYHIX
- Amgen Inc — 1.56%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
- Pfizer Inc — 1.25%
- Mckesson Corp — 1.05%
- Elevance Health Inc — 1.02%
- Cigna Group (the) — 0.94%
- Hca Healthcare Inc — 0.87%
- Boston Scientific Corp — 0.86%
- Novo Nordisk A/s — 0.83%
Asset mix
| Asset type | JDOC | RYHIX |
|---|---|---|
| Stocks | 99.2% | 83.2% |
| Repurchase agreements | — | 0.9% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | JDOC | RYHIX |
|---|---|---|
| US | 75.2% | 73.0% |
| GB | 6.2% | 1.8% |
| CH | 4.4% | 2.3% |
| DK | 4.0% | 1.4% |
| IE | 0.4% | 3.3% |
| JP | 2.5% | — |
| NL | 2.4% | 0.7% |
| DE | 1.9% | 0.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do JDOC and RYHIX overlap?
What stocks do JDOC and RYHIX have in common?
Should I own both JDOC and RYHIX?
Which holds more stocks, JDOC or RYHIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.